OUR PRODUCTS

MOBILE APPS

GENERAL INFO

KYTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Kyverna Therapeutics (KYTX) Earnings Date & Reports

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

KYTX is expected to report earnings to rise 5.15% to -101 cents per share on November 12

Kyverna Therapeutics KYTX Stock Earnings Reports

Q3'25

Est.

$-1.02

Q2'25

Beat

by $0.05

Q4'24

Beat

by $0.08

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.11

The last earnings report on August 12 showed earnings per share of -97 cents, beating the estimate of -101 cents. With 199.74K shares outstanding, the current market capitalization sits at 160.01M.

View a ticker or compare two or three

Compare

KYTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For KYTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KYTX showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

5980 Horton Street

Phone

+1 510 925-2492

Employees

Web

https://www.kyvernatx.com